Abstract

Studies in vivo and in vitro have suggested that the mechanism underlying Alzheimer’s disease (AD) neuropathogenesis is initiated by an interaction between the cellular prion protein (PrPC) and amyloid-β oligomers (Aβo). This PrPC-Aβo complex activates Fyn kinase which, in turn, hyperphosphorylates tau (P-Tau) resulting in synaptic dysfunction, neuronal loss and cognitive deficits. AD transgenic mice lacking PrPC accumulate Aβ, but show normal survival and no loss of spatial learning and memory suggesting that PrPC functions downstream of Aβo production but upstream of intracellular toxicity within neurons. Since AD and traumatic brain injury (TBI)-linked chronic traumatic encephalopathy are tauopathies, we examined whether similar mechanistic pathways are responsible for both AD and TBI pathophysiologies. Using transgenic mice expressing different levels of PrPC, our studies investigated the influence and necessity of PrPC on biomarker (total-tau [T-Tau], P-Tau, GFAP) levels in brain and blood as measured biochemically following severe TBI in the form of severe closed head injury (sCHI). We found that following sCHI, increasing levels of T-Tau and P-Tau in the brain were associated with the PrPC expression levels. A similar relationship between PrPC expression and P-Tau levels following sCHI were found in blood in the absence of significant T-Tau changes. This effect was not seen with GFAP which increased within 24 h following sCHI and progressively decreased by the 7 day time point regardless of the PrPC expression levels. Changes in the levels of all biomarkers were independent of gender. We further enhanced and expanded the quantitation of brain biomarkers with correlative studies using immunohisochemistry. We also demonstrate that a TBI-induced calpain hyperactivation is not required for the generation of P-Tau. A relationship was demonstrated between the presence/absence of PrPC, the levels of P-Tau and cognitive dysfunction. Our studies suggest that PrPC is important in mediating TBI related pathology.

Highlights

  • The cellular prion protein (PrPC) is a host-coded membrane-bound glycoprotein containing a glycosylphosphatidylinositol anchor

  • We have previously demonstrated that WT, Tga20 and PrP knockout (PrPKO) mice subjected to severe closed head injury (sCHI) resulted in calpain activation as demonstrated by the appearance of α-II-spectrin breakdown products (SBDPs)

  • We examined the influence of calpain activity on the levels of T-Tau, P-Tau and glial fibrillary acidic protein (GFAP) after sCHI by treating the impacted mice with the calpain inhibitor, SNJ1945

Read more

Summary

Introduction

The cellular prion protein (PrPC) is a host-coded membrane-bound glycoprotein containing a glycosylphosphatidylinositol anchor. Fyn regulates glutamate receptor trafficking and synaptic plasticity by phosphorylating Nmethyl-D-aspartate glutamate receptor (NMDA-R) subunits NR2A and NR2B [14, 19, 30, 35, 49] which play an important role in learning and memory [26, 28]. Both PrPC and Fyn have been localized to post-synaptic density (PSD)-containing brain fractions which is the primary post-synaptic site for signal transduction and processing in neurons

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call